Talks

BEES-HAUS cell therapy for male urethral stricture; pilot clinical study.

Augmenting cancer treatment efficacy through Immune Enhancement by immune-cell therapies.

Autologous NK cell based Immune cell therapy for cancer & for immune enhancement.

Clinical Trial Outcome of Neu REFIX Beta Glucans in Patients with Psoriasis.

A global, Inter-disciplinary interaction among scientists and clinicians to develop solutions for a rare genetic disease: Duchenne Muscular Dystrophy.

Novel health care solutions from Japan: Adjuvants to cell therapies in Ophthalmology, Oncology, Urology and rare diseases.

Novel B-glucan based disease modifying treatment adjuvant in Duchenne muscular dystrophy.

Immune health: Ingredient science, consumer trends and market opportunities.

Proven cell engraftment on ocular surface, yielding successful cell therapy in Urethral stricture.

Corneal regeneration using autologous and allogenic donor-corneal derived cells using nanocomposite materials. 3 in 1 program.

A novel autologous buccal mucosal cell therapy for male urethral stricture; BEES-HAUS Technique.

Three thoughts for collaborative research in Oncology; Simple, Tedious & Futuristic.

Clinical application of autologous bone marrow mononuclear cells in patients with terminal stage of heart failure and our study of futuristic cell therapy in myocardial regeneration.

A novel solution for urethral repair – the BEES HAUS procedure.

An overview of Regenerative Medicine Scenario in India & our 12-year experience of Indo-Japan bridging.

Stem cell therapy in regenerative medicine: present status and future prospects in India.

Autologous NK cell and T cell combination in treating cancer & cell therapy regulations in Japan.

Autologous Immune Enhancement Therapy (AIET) and Boron Neutron Capture Therapy (BNCT) for Cancer.

Autologous Immune Enhancement Therapy (AIET) for Cancer.

Cell based therapies coming of age.

Stem cell based applications in Oncology, Ophthalmology, Orthopaedics, Urology and Cosmetology.

Two novel approaches to address Corneal Epithelial Damage using Autologous Limbal Stem Cells or Buccal Mucosal Epithelium.

Guest Lecture on Applications of Stem Cells and Regenerative Medicine in Clinical settings with special emphasis on ophthalmology.

What's next for Stem Cells & Regenerative Medicine.

AIET for Cancer; long term results and our Indian experience.

International linkages for enhancing competence and Growth.

Successful transportation of human cadaver corneal endothelial tissue in a polymer cocktail, expansion of its precursors, their transplantation to cadaver bulls eye and to patients with bullous keratopathy using a nanocomposite gel sheet.

Physico-chemical nurturing of the 'Cell' – A tool for Rejuvenation.

Personalized treatment for cancer using autologous immune cells.

Regenerative medicine in repair of bones and cartilage.

Cell Therapy approach for Corneal Diseases.

Our experience in Translation of Stem Cell Therapy in Spinal Cord Injury.

Immune Cells, intricacies and co-existing potentials in tackling cancers and viruses.

Autologous NK cell based Immune Enhancement Therapy (AIET) for Cancer.

Constructive angiogenesis in regenerative medicine and destructive angiogenesis in cancer; commonalities and clues to learn.

Stem cells for spinal cord injury.

In vitro expansion of CD34 cell population of human cord blood and bone marrow derived mononuclear cells using synthetic scaffolds.

Biomimicry – Our perspectives on biomimicking nano materials and environments favouring tissue engineering.

Invited lecture.

What does the future hold for stem cell research and therapies.

Our Approach to Cell Therapeutics using Hybrid Biomaterials.

Culturing, tissue engineering and re-implantation of stem cells using cell / tissue specific hybrid biomaterials.

In vitro expansion of clinically usable stem cells and progenitor cells for cell therapeutics and in vivo implantation in animal models; our experience.